US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist

1.3850
-0.1837-11.71%

Close Apr 26 16:00 ET

6.14MMarket Cap-1204P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

27.24%4.53M

84.85%1.21M

54.94%1.43M

79.64%1.14M

-44.88%739.29K

-14.07%3.56M

-23.85%655.78K

20.92%924.06K

-51.36%636.67K

11.20%1.34M

Selling and administrative expenses

-38.68%1.21M

-49.58%200.8K

-27.21%307.68K

-35.45%307.36K

-41.73%391.26K

-34.46%1.97M

-44.27%398.26K

-16.61%422.69K

-59.24%476.16K

9.38%671.44K

-General and administrative expense

-38.68%1.21M

-49.58%200.8K

-27.21%307.68K

-35.45%307.36K

-41.73%391.26K

-34.46%1.97M

-44.27%398.26K

-16.61%422.69K

-59.24%476.16K

9.38%671.44K

Research and development costs

108.90%3.32M

292.76%1.01M

124.19%1.12M

421.06%836.38K

-48.04%348.03K

39.80%1.59M

75.70%257.52K

94.87%501.37K

14.17%160.52K

13.08%669.84K

Operating profit

-27.24%-4.53M

-84.85%-1.21M

-54.94%-1.43M

-79.64%-1.14M

44.88%-739.29K

14.07%-3.56M

23.85%-655.78K

-20.92%-924.06K

51.36%-636.67K

-11.20%-1.34M

Net non-operating interest income expense

224.40%156.79K

-32.52%40.81K

253.55%37.26K

881.20%53.1K

261.43%25.63K

110.42%48.33K

326.63%60.47K

109.23%10.54K

97.16%-6.8K

81.08%-15.88K

Non-operating interest income

42.35%264.48K

-41.95%53.66K

62.88%69.22K

157.47%84.71K

216.65%56.89K

459.49%185.79K

183.18%92.43K

12,547.62%42.5K

14,393.39%32.9K

359,240.00%17.97K

Non-operating interest expense

-21.66%107.68K

-59.78%12.85K

0.00%31.96K

-20.37%31.61K

-7.63%31.26K

-72.34%137.46K

-46.13%31.96K

-72.08%31.96K

-83.40%39.7K

-59.68%33.84K

Other net income (expense)

-1,268.74%-630.32K

-8,222.56%-504.76K

81.54%-2.18K

-411.69%-118.95K

10.57%-4.43K

-156.72%-46.05K

-143.97%-6.07K

-11.78K

-23.25K

-105.92%-4.96K

Gain on sale of security

-1,268.74%-630.32K

-7,876.31%-483.76K

-96.66%-23.18K

-411.69%-118.95K

10.57%-4.43K

-156.72%-46.05K

-143.97%-6.07K

---11.78K

---23.25K

-105.92%-4.96K

Other non- operating income (expenses)

----

--21K

----

Income before tax

-40.64%-5M

-178.73%-1.68M

-50.94%-1.4M

-81.42%-1.21M

47.28%-718.1K

21.39%-3.56M

32.46%-601.37K

-5.35%-925.31K

56.92%-666.72K

-12.90%-1.36M

Income tax

Net income

-40.64%-5M

-178.73%-1.68M

-50.94%-1.4M

-81.42%-1.21M

47.28%-718.1K

21.39%-3.56M

32.46%-601.37K

-5.35%-925.31K

56.92%-666.72K

-12.90%-1.36M

Net income continuous Operations

-40.64%-5M

-178.73%-1.68M

-50.94%-1.4M

-81.42%-1.21M

47.28%-718.1K

21.39%-3.56M

32.46%-601.37K

-5.35%-925.31K

56.92%-666.72K

-12.90%-1.36M

Minority interest income

Net income attributable to the parent company

-40.64%-5M

-178.73%-1.68M

-50.94%-1.4M

-81.42%-1.21M

47.28%-718.1K

21.39%-3.56M

32.46%-601.37K

-5.35%-925.31K

56.92%-666.72K

-12.90%-1.36M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-40.64%-5M

-178.73%-1.68M

-50.94%-1.4M

-81.42%-1.21M

47.28%-718.1K

21.39%-3.56M

32.46%-601.37K

-5.35%-925.31K

56.92%-666.72K

-12.90%-1.36M

Basic earnings per share

-40.24%-1.15

-171.43%-0.38

-52.38%-0.32

-86.67%-0.28

46.88%-0.17

33.87%-0.82

30.00%-0.14

-5.00%-0.21

65.91%-0.15

27.27%-0.32

Diluted earnings per share

-40.24%-1.15

-171.43%-0.38

-52.38%-0.32

-86.67%-0.28

46.88%-0.17

33.87%-0.82

30.00%-0.14

-5.00%-0.21

65.91%-0.15

27.27%-0.32

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	27.24%4.53M	84.85%1.21M	54.94%1.43M	79.64%1.14M	-44.88%739.29K	-14.07%3.56M	-23.85%655.78K	20.92%924.06K	-51.36%636.67K	11.20%1.34M
Selling and administrative expenses	-38.68%1.21M	-49.58%200.8K	-27.21%307.68K	-35.45%307.36K	-41.73%391.26K	-34.46%1.97M	-44.27%398.26K	-16.61%422.69K	-59.24%476.16K	9.38%671.44K
-General and administrative expense	-38.68%1.21M	-49.58%200.8K	-27.21%307.68K	-35.45%307.36K	-41.73%391.26K	-34.46%1.97M	-44.27%398.26K	-16.61%422.69K	-59.24%476.16K	9.38%671.44K
Research and development costs	108.90%3.32M	292.76%1.01M	124.19%1.12M	421.06%836.38K	-48.04%348.03K	39.80%1.59M	75.70%257.52K	94.87%501.37K	14.17%160.52K	13.08%669.84K
Operating profit	-27.24%-4.53M	-84.85%-1.21M	-54.94%-1.43M	-79.64%-1.14M	44.88%-739.29K	14.07%-3.56M	23.85%-655.78K	-20.92%-924.06K	51.36%-636.67K	-11.20%-1.34M
Net non-operating interest income expense	224.40%156.79K	-32.52%40.81K	253.55%37.26K	881.20%53.1K	261.43%25.63K	110.42%48.33K	326.63%60.47K	109.23%10.54K	97.16%-6.8K	81.08%-15.88K
Non-operating interest income	42.35%264.48K	-41.95%53.66K	62.88%69.22K	157.47%84.71K	216.65%56.89K	459.49%185.79K	183.18%92.43K	12,547.62%42.5K	14,393.39%32.9K	359,240.00%17.97K
Non-operating interest expense	-21.66%107.68K	-59.78%12.85K	0.00%31.96K	-20.37%31.61K	-7.63%31.26K	-72.34%137.46K	-46.13%31.96K	-72.08%31.96K	-83.40%39.7K	-59.68%33.84K
Other net income (expense)	-1,268.74%-630.32K	-8,222.56%-504.76K	81.54%-2.18K	-411.69%-118.95K	10.57%-4.43K	-156.72%-46.05K	-143.97%-6.07K	-11.78K	-23.25K	-105.92%-4.96K
Gain on sale of security	-1,268.74%-630.32K	-7,876.31%-483.76K	-96.66%-23.18K	-411.69%-118.95K	10.57%-4.43K	-156.72%-46.05K	-143.97%-6.07K	---11.78K	---23.25K	-105.92%-4.96K
Other non- operating income (expenses)	----	----	--21K	----	----	----	----	----	----	----
Income before tax	-40.64%-5M	-178.73%-1.68M	-50.94%-1.4M	-81.42%-1.21M	47.28%-718.1K	21.39%-3.56M	32.46%-601.37K	-5.35%-925.31K	56.92%-666.72K	-12.90%-1.36M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-40.64%-5M	-178.73%-1.68M	-50.94%-1.4M	-81.42%-1.21M	47.28%-718.1K	21.39%-3.56M	32.46%-601.37K	-5.35%-925.31K	56.92%-666.72K	-12.90%-1.36M
Net income continuous Operations	-40.64%-5M	-178.73%-1.68M	-50.94%-1.4M	-81.42%-1.21M	47.28%-718.1K	21.39%-3.56M	32.46%-601.37K	-5.35%-925.31K	56.92%-666.72K	-12.90%-1.36M
Minority interest income
Net income attributable to the parent company	-40.64%-5M	-178.73%-1.68M	-50.94%-1.4M	-81.42%-1.21M	47.28%-718.1K	21.39%-3.56M	32.46%-601.37K	-5.35%-925.31K	56.92%-666.72K	-12.90%-1.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-40.64%-5M	-178.73%-1.68M	-50.94%-1.4M	-81.42%-1.21M	47.28%-718.1K	21.39%-3.56M	32.46%-601.37K	-5.35%-925.31K	56.92%-666.72K	-12.90%-1.36M
Basic earnings per share	-40.24%-1.15	-171.43%-0.38	-52.38%-0.32	-86.67%-0.28	46.88%-0.17	33.87%-0.82	30.00%-0.14	-5.00%-0.21	65.91%-0.15	27.27%-0.32
Diluted earnings per share	-40.24%-1.15	-171.43%-0.38	-52.38%-0.32	-86.67%-0.28	46.88%-0.17	33.87%-0.82	30.00%-0.14	-5.00%-0.21	65.91%-0.15	27.27%-0.32
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall